Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2012
06/13/2012CN101637454B Recombinant human bone morphogenetic protein-2 chitosan microballon and preparation method thereof
06/13/2012CN101606905B Nitazoxanide suspension for expelling parasite in livestock body and preparation method thereof
06/13/2012CN101524462B Garlic volatile oil composition, preparation method of cream preparation thereof and application of cream preparation to treating microbial infection of skin and mucous membrane
06/13/2012CN101516339B Method for making solid dispersions of highly crystalline therapeutic compounds
06/13/2012CN101496831B Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases
06/13/2012CN101474260B Shuang Huanglian liquid preparation and method for measuring content thereof
06/13/2012CN101460153B Non-homogenous dosage form coatings
06/13/2012CN101453989B Process for preparing spray dried formulations of TMC125
06/13/2012CN101444618B Pharmaceutical preparation containing exenatide
06/13/2012CN101389221B Silver/water, silver gels and silver-based compositions, method for fabricating and using the same
06/13/2012CN101352432B Technique of preparing nano vitamin E emulsion
06/13/2012CN101167759B Mushroom fermentation dry powder preparation with anti-tumor activity and preparation method
06/13/2012CN101141978B Pharmaceutical preparation that can be administered orally for treating fish, production method for said preparation and use of the latter
06/13/2012CN101123949B Medicine lipid composition
06/13/2012CN101087590B Solid dosage form comprising proton pump inhibitor and suspension made thereof
06/13/2012CN100998785B Traditional Chinese medicine composition for treating gastrointestinal disease and its preparing method
06/12/2012US8198400 Liposomal vaccines containing immunogenic lipopeptides from tuberculosis, malaria, and hepatitis B peptides
06/12/2012US8198354 Pharmaceutical metered dose inhaler and methods relating thereto
06/12/2012US8198291 Intranasal opioid compositions
06/12/2012US8198265 Regulation of T cell-mediated immunity by tryptophan
06/12/2012US8198238 Flowable carrier matrix and methods for delivering to a patient
06/12/2012US8197871 Composition for headache treatment
06/12/2012US8197864 Preparation, process and a regenerative method and technique for prevention, treatment and glycemic control of diabetes mellitus
06/12/2012US8197851 Carotenoid composition and method for preparation thereof
06/12/2012US8197850 increase in the time corresponding to the plasma concentration maximum, without a very significant decrease in the bioavailability; comprises several thousand anti-hyperglycaemic (metformin) microcapsules; drug core with coating film
06/12/2012US8197849 Cross-linked oxidated hyaluronic acid for use as a vitreous substitute
06/12/2012US8197848 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
06/12/2012US8197847 Process for making polymers and supports comprising pendant sugar side groups
06/12/2012US8197846 Sustained release pharmaceutical composition
06/12/2012US8197845 Encapsulated tiotropium containing powder formulation for inhalation
06/12/2012US8197843 Device for the administration of an active agent to the human skin
06/12/2012US8197842 Dietary supplement and method
06/12/2012US8197839 A miniature coated tablet or covered rod implant; smaller size and larger payloads than immediate release tablets; veterinary medicine
06/12/2012US8197838 Sustained release systems of ascorbic acid phosphate
06/12/2012US8197828 Compositions that include a hydrophobic compound and a polyamino acid conjugate
06/12/2012US8197715 Thermoplastic moulding compositions having improved ductility
06/12/2012US8197461 Controlled release system for delivering therapeutic agents into the inner ear
06/12/2012CA2681962C Methods of administering epothilone analogs for the treatment of cancer
06/12/2012CA2648667C Sustained-release tablet production process
06/12/2012CA2543068C Process for producing 1-octene from butadiene in the presence of titanium catalysts
06/12/2012CA2522146C Uptake of macromolecules
06/12/2012CA2512198C Development of an anti-cough, anti-tussive and throat soothing herbal formulation
06/12/2012CA2481486C Multi-phase, multi-compartment capsular system
06/12/2012CA2413251C Compositions and methods to improve the oral absorption of antimicrobial agents
06/12/2012CA2404325C Immunotherapeutic methods and compositions
06/10/2012CA2761472A1 Method of altering reaction time
06/10/2012CA2761404A1 Sheet-form preparation and method for producing the same
06/10/2012CA2761402A1 Sheet-form preparation and method for producing the same
06/07/2012WO2012075455A2 Rapidly dispersing granules, orally disintegrating tablets and methods
06/07/2012WO2012075451A2 Clonidine and gaba compounds in a biodegradable polymer carrier
06/07/2012WO2012075447A2 Compositions and methods for delivering clonidine and bupivacaine to a target tissue site
06/07/2012WO2012075443A2 Methods for delivering clonidine compositions in a biodegradable polymer carrier and local steriods to a target tissue site
06/07/2012WO2012075440A2 Compositions and methods for delivering clonidine to a target tissue site
06/07/2012WO2012075414A2 Aptamer bioconjugate drug delivery device
06/07/2012WO2012075379A2 Liquid viral formulations
06/07/2012WO2012075376A2 Lyophilized viral formulations
06/07/2012WO2012075373A2 Solid dosage form that promotes reliable oral, esophageal and gi transit
06/07/2012WO2012075337A2 Directed delivery of agents to neural anatomy
06/07/2012WO2012075296A1 Dissolvable pharmaceutical implant
06/07/2012WO2012075253A2 Pharmaceutical compositions
06/07/2012WO2012075244A2 Use of hemoglobin effectors to increase the bioavailability of therapeutic gases
06/07/2012WO2012075194A1 Capsule and powder formulations containing lanthanum compounds
06/07/2012WO2012075184A2 Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof
06/07/2012WO2012075174A2 Compounds and methods for skin repair
06/07/2012WO2012075087A2 Silica nanoparticle agent conjugates
06/07/2012WO2012075081A2 High-strength testosterone undecanoate compositions
06/07/2012WO2012075015A2 Oral metronidazole pharmaceutical compositions
06/07/2012WO2012074988A1 Rotigotine ionic liquid
06/07/2012WO2012074830A2 Modified release tranexamic acid formulation
06/07/2012WO2012074440A2 Pharmacological composition intended for intra-nasal administration with the aim of supplying a pharmacologically active component to the brain, and method for producing said composition
06/07/2012WO2012074401A1 Prevention or treatment of overweight and obesity in type 2 diabetic patients
06/07/2012WO2012074375A1 Prevention or treatment of overweight and obesity in type 2 diabetic patients
06/07/2012WO2012074245A2 Mineral composition, and preparation method thereof
06/07/2012WO2012074244A2 Injectable liquid composition or injectable dried powder containing revaprazan or its salt
06/07/2012WO2012074243A2 Injectable liquid composition containing revaprazan or its salt
06/07/2012WO2012074231A2 Pharmaceutical composition including mometasone furoate and azelastine hydrochloride for nasal administration
06/07/2012WO2012074120A1 Lissencephaly therapeutic agent
06/07/2012WO2012074110A1 Orally disintegrating tablet
06/07/2012WO2012074042A1 Hydroxyalkyl cellulose
06/07/2012WO2012074037A1 Breast enhancement accelerator
06/07/2012WO2012073891A1 Transfusion preparation
06/07/2012WO2012073856A1 Oil-in-water emulsion composition containing difluprednate and tobramycin
06/07/2012WO2012073191A1 Topical compositions for preserving or restoring the integrity of mucosae
06/07/2012WO2012073188A1 Chemoembolization composition comprising anti-angiogenic agents
06/07/2012WO2012073170A2 Galenic composition suitable for administration to a non-human animal, uses thereof, and associated methods
06/07/2012WO2012073125A1 Tsh-conjugated nanocarrier for the treatment of thyroid cancer
06/07/2012WO2012073079A1 Microcapsule
06/07/2012WO2012072977A2 Compound formulations
06/07/2012WO2012072692A2 Use of cytokine-releasing, biodegradable particles in hyaluronic acid for the treatment of cartilage defects, in particular of osteoarthrosis
06/07/2012WO2012072650A1 Transdermal therapeutic system (tts) comprising rotigotine
06/07/2012WO2012072587A1 Biodegradable natural films based on co-products derived from industrial seed-processing processes
06/07/2012WO2012072580A1 Compressed formulations of ordered mesoporous silicas
06/07/2012WO2012072570A2 Process for the preparation of a ppi-containing pharmaceutical product
06/07/2012WO2012072374A1 Priming solutions for cardiopulmonary bypass
06/07/2012WO2012072256A2 Once daily formulation of lacosamide
06/07/2012WO2012072055A1 Use of pacap for treating viral infections in aquatic organisms
06/07/2012WO2012072014A1 Transdermal patch preventing volatilization of rasagiline
06/07/2012WO2012072012A1 Microcapsule preparation of alginate-chitosan acyl derivatives, preparation and application thereof
06/07/2012WO2012072006A1 Liposome lyophilized composition of water soluble drug and preparation process thereof
06/07/2012WO2012071654A1 Treatment and prevention of eczema
1 ... 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 ... 2991